Vivos Therapeutics, Inc. Contracts & Agreements
38 Contracts & Agreements
- Business Finance (28 contracts)
- Business Operations (3)
- Human Resources (5)
- Uncategorized (2)
- Warrant Inducement Agreement, dated February 14, 2024, by and between the Company and the Holder (Filed With SEC on February 15, 2024)
- Form of Series B-2 Common Stock Purchase Warrant (Filed With SEC on February 15, 2024)
- Form of Series B-1 Common Stock Purchase Warrant (Filed With SEC on February 15, 2024)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on November 2, 2023)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on November 2, 2023)
- January 2023 Warrant Amendment (Filed With SEC on November 2, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on November 2, 2023)
- Form of Securities Purchase Agreement, dated October 30, 2023, between the Company and the Purchaser (Filed With SEC on November 2, 2023)
- Form of Registration Rights Agreement, dated October 30, 2023, between the Company and the Purchaser (Filed With SEC on November 2, 2023)
- Placement Agency Agreement, dated October 30, 2023, between the Company and the Placement Agent (Filed With SEC on November 2, 2023)
- Placement Agency Agreement, dated January 5, 2023, between the Company and the Placement Agents (Filed With SEC on January 9, 2023)
- Form of Registration Rights Agreement, dated January 5, 2023, between the Company and the Purchaser (Filed With SEC on January 9, 2023)
- Form of Securities Purchase Agreement, dated January 5, 2023, between the Company and the Purchaser (Filed With SEC on January 9, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on January 9, 2023)
- Form of Common Stock Warrant (Filed With SEC on January 9, 2023)
- Sabbatical Agreement dated September 22, 2021, by and between Vivos Therapeutics, Inc. and Dr. G. Dave Singh (Filed With SEC on September 27, 2021)
- Representatives Warrant, dated May 11, 2021 (Filed With SEC on May 12, 2021)
- Underwriting Agreement, dated May 6, 2021, by and between the Company and Roth, as representative of the several underwriters (Filed With SEC on May 12, 2021)
- Form of Representatives Warrant (Filed With SEC on May 3, 2021)
- Form of Underwriting Agreement (Filed With SEC on May 3, 2021)
- Licensing, Distribution, and Marketing Agreement dated February 12, 2021 between the Company and MyCardio, LLC (Filed With SEC on March 25, 2021)
- Description of Registered Securities (Filed With SEC on March 25, 2021)
- Form of Representatives Warrant, dated December 15, 2020 (Filed With SEC on December 15, 2020)
- Underwriting Agreement, dated December 10, 2020, by and between the Company and Roth, as representative of the several underwriters (Filed With SEC on December 15, 2020)
- Form of Representatives Warrant (Filed With SEC on November 19, 2020)
- Form of Underwriting Agreement (Filed With SEC on November 19, 2020)
- Amended and Restated Executive Employment Agreement, dated October 8, 2020, between R. Kirk Huntsman and Vivos Therapeutics, Inc (Filed With SEC on October 26, 2020)
- Amended and Restated Executive Employment Agreement, dated October 8, 2020, between Bradford Amman and Vivos Therapeutics, Inc (Filed With SEC on October 26, 2020)
- Form of Stock Certificate (Filed With SEC on October 9, 2020)
- Vivos Therapeutics, Inc. 2019 Stock Option and Stock Issuance Plan (Filed With SEC on October 9, 2020)
- Amended and Restated Executive Employment Agreement, dated October 8, 2020, between Bradford Amman and Vivos Therapeutics, Inc (Filed With SEC on October 9, 2020)
- Amended and Restated Executive Employment Agreement, dated October 9, 2020, between G. Dave Singh and Vivos Therapeutics, Inc (Filed With SEC on October 9, 2020)
- Amended and Restated Executive Employment Agreement, dated October 8, 2020, between R. Kirk Huntsman and Vivos Therapeutics, Inc (Filed With SEC on October 9, 2020)
- Security Agreement, dated May 6, 2017, by and between Vivos Biotechnologies, Inc. and Dr. Gurdev Dave Singh (Filed With SEC on October 9, 2020)
- Intellectual Property & Asset Purchase Agreement, dated May 4, 2017, by and between Vivos Biotechnologies, Inc. and Dr. Gurdev Dave Singh (Filed With SEC on October 9, 2020)
- Amendment to Share Exchange Agreement, dated September 15, 2016, among Vivos Therapeutics, Inc., BioModeling Solutions, Inc., shareholders of BioModeling Solutions, Inc., First... (Filed With SEC on October 9, 2020)
- Share Exchange Agreement, dated August 16, 2016, among Vivos Therapeutics, Inc., BioModeling Solutions, Inc., shareholders of BioModeling Solutions, Inc., First Vivos, Inc., and... (Filed With SEC on October 9, 2020)
- Vivos Therapeutics, Inc. 2017 Stock Option and Stock Issuance Plan (Filed With SEC on October 9, 2020)
